Jalota Deepika

Chief Development Officer at PMVP

Sold, on record
$171k
Dollars the filings state
Form 4 sales
4
Latest Jul 1, 2025
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • PMVPPMV Pharmaceuticals, Inc.Chief Development Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale PMVPUnusual
    Aug 17, 2021 2021

    Sold 2,896 shares at $33.78 ($98k)

    Jalota Deepika, SVP, Regulatory Affairs and QA

    Sold 100% of holdings ($98k position)0 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale PMVPNo plan
    Sep 15, 2023 +759 days

    Sold 4,104 shares at $6.62 ($27k)

    Jalota Deepika, Chief Development Officer

    No 10b5-1 planSold 12.1% of holdings ($225k position)29,946 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale PMVPNo plan
    Sep 11, 2024 +362 days

    Sold 7,218 shares at $1.50 ($11k)

    Jalota Deepika, Chief Development Officer

    No 10b5-1 planSold 5.8% of holdings ($188k position)118,283 shares leftFiling

  4. 4 Form 4 sale PMVPUnusual
    Jul 1, 2025 +293 days

    Sold 33,065 shares at $1.06 ($35k)

    Jalota Deepika, Chief Development Officer

    No 10b5-1 planSold 26.9% of holdings ($130k position)89,959 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Jalota Deepika
Source
Jul 1, 2025Jul 3, 2025PMVPChief Development OfficerForm 4 sale33,065$35k26.9%UnusualSEC
Sep 11, 2024Sep 12, 2024PMVPChief Development OfficerForm 4 sale7,218$11k5.8%No planSEC
Sep 15, 2023Sep 18, 2023PMVPChief Development OfficerForm 4 sale4,104$27k12.1%No planSEC
Aug 17, 2021Aug 18, 2021PMVPSVP, Regulatory Affairs and QAForm 4 sale2,896$98k100.0%UnusualSEC